| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 02/21/1996 | EP0560795B1 38-decarboxy-38-hydroxymethyl derivatives of teicoplanin antibiotics, and a process for preparing them |
| 02/20/1996 | US5493008 Two non-contiguous regions contribute to nidogen binding to a single EGF-like motif of the laminin γ1 chain |
| 02/20/1996 | US5493007 Oligopeptide |
| 02/20/1996 | US5492893 Sterilization of animals; therapy od sex hormone relateddiseases |
| 02/15/1996 | WO1996004308A1 Cyclic hexapeptide somatostatin analogues |
| 02/15/1996 | WO1996004300A1 Methods and compositions for differential diagnosis of acute and chronic hepatitis c virus infection |
| 02/15/1996 | WO1996004299A1 Streptogramine derivatives, preparation of same and pharmaceutical compositions containing same |
| 02/15/1996 | WO1996004298A1 Purified form of streptogramines, preparation of same and pharmaceutical compositions containing same |
| 02/15/1996 | WO1996004002A1 Remedy for corneal diseases |
| 02/15/1996 | CA2196687A1 Corneal therapeutic agent |
| 02/15/1996 | CA2196450A1 Purified form of streptogramines, preparation of same and pharmaceutical compositions containing same |
| 02/15/1996 | CA2196195A1 Methods and compositions for differential diagnosis of acute and chronic hepatitis c virus infection |
| 02/15/1996 | CA2196102A1 Streptogramine derivatives, preparation of same and pharmaceutical compositions containing same |
| 02/14/1996 | EP0696323A1 Recombinant alanine racemase and gapdh from tolypocladium |
| 02/14/1996 | EP0696318A1 Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies |
| 02/14/1996 | EP0696203A1 Use of ceruletide diethyl amine salt in the treatment of psoriasis |
| 02/14/1996 | EP0696202A1 Pharmaceutical composition containing thymoctonan and azt |
| 02/14/1996 | EP0696199A1 Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes |
| 02/14/1996 | CN1116628A Cyclopeptides of the formulal |
| 02/13/1996 | US5491217 LHRH antagonists having modified aminoacyl residues at positions 5 and 6 |
| 02/13/1996 | US5491130 Peptide inhibitors of fibronectin and related collagen-binding proteins |
| 02/13/1996 | US5491129 Synthetic peptides derived from vitronectin and pharmaceutical compositions comprising them |
| 02/13/1996 | US5491128 Aglycons of A/16686 antibiotics |
| 02/13/1996 | US5491074 Joining peptides by attaching association hexapeptide to each, mixing fusion complexes formed to dimerize association peptide |
| 02/13/1996 | US5491073 Cloning of chicken anaemia DNA |
| 02/08/1996 | WO1996003652A1 Determination of a specific immunoglobulin using multiple antigens |
| 02/08/1996 | WO1996003651A1 Peptides marked with metal chelates |
| 02/08/1996 | WO1996003649A1 Src SH3 BINDING PEPTIDES AND METHODS OF ISOLATING AND USING SAME |
| 02/08/1996 | WO1996003522A1 Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same |
| 02/08/1996 | WO1996003519A1 Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same |
| 02/08/1996 | WO1996003430A1 Organic compounds |
| 02/08/1996 | WO1996003429A1 Stable analogs of bioactive peptides containing disulfide linkages |
| 02/08/1996 | WO1996003423A1 Hapten-marked peptides |
| 02/08/1996 | WO1996003140A1 HLA binding peptides and their uses |
| 02/08/1996 | WO1996003138A1 Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens |
| 02/08/1996 | CA2195671A1 Hla binding peptides and their uses |
| 02/08/1996 | CA2195648A1 Metal chelate-labelled peptides |
| 02/08/1996 | CA2195629A1 Src sh3 binding peptides and methods of isolating and using same |
| 02/08/1996 | CA2195525A1 Stable analogs of bioactive peptides containing disulfide linkages |
| 02/07/1996 | EP0695759A2 Human cancer inhibitory pentapeptide methyl esters |
| 02/07/1996 | EP0695758A2 Human cancer inhibitory pentapeptide amides and esters |
| 02/07/1996 | EP0695309A1 Oxytocin antagonist |
| 02/07/1996 | EP0671930A4 Prophylaxis and treatment of adverse oral conditions with biologically active peptides. |
| 02/07/1996 | CN1116427A Polypeptide and anti-hiv agent prepared therefrom |
| 02/06/1996 | US5489678 Photolabile nucleoside and peptide protecting groups |
| 02/06/1996 | US5489670 Laxatives; control intestinal fluid absorption |
| 02/06/1996 | US5489668 Immunoassay reagents and method for determining cyclosporine |
| 02/02/1996 | CA2154206A1 Human cancer inhibitory pentapeptide amides and esters |
| 02/02/1996 | CA2154203A1 Pentapeptide methyl esters |
| 02/01/1996 | WO1996002643A1 Denervated muscle kinase (dmk), a receptor of the tyrosine kinase super family |
| 02/01/1996 | WO1996002572A2 Antigenic polypeptide sequence of factor viii, fragments and/or epitopes thereof |
| 02/01/1996 | WO1996002568A1 Complexes for use in the diagnosis of vascular diseases |
| 02/01/1996 | WO1996002566A1 Vitronectin binding protein |
| 02/01/1996 | WO1996002561A1 Interaction trap systems for detecting protein interactions |
| 02/01/1996 | WO1996002558A1 Linked peptide nucleic acids |
| 02/01/1996 | WO1996002500A1 Technetium-sulphonamide complexes, their use, pharmaceutical agents containing them, and process for producing the complexes and agents |
| 02/01/1996 | WO1996002286A1 Compositions and methods for a bioartificial extracellular matrix |
| 02/01/1996 | WO1996002267A1 Peptide, a method of obtaining it and a pharmaceutical compound based on it |
| 02/01/1996 | DE4439347A1 New rare earth or transition metal complexes contg. charged linker |
| 02/01/1996 | DE4439346A1 New rare earth or transition metal complexes contg. hydrophilic gps. |
| 02/01/1996 | DE4439345A1 New conjugates comprising oligomeric carrier and attached hapten(s) |
| 02/01/1996 | DE4430998A1 Metallchelat-markierte Peptide Metal chelate-labeled peptides |
| 02/01/1996 | DE4430973A1 Hapten-markierte Peptide Hapten-labeled peptides |
| 02/01/1996 | DE4430972A1 Bestimmung von spezifischem Immunglobulin unter Verwendung multipler Antigene Determination of specific immunoglobulin using multiple antigens |
| 02/01/1996 | CA2195126A1 Antigenic polypeptide sequence of factor viii, fragments and/or epitopes thereof |
| 02/01/1996 | CA2194561A1 Technetium-sulphonamide complexes, their use, pharmaceutical agents containing them, and process for producing the complexes and agents |
| 02/01/1996 | CA2194493A1 Compositions and methods for a bioartificial extracellular matrix |
| 01/31/1996 | EP0694041A1 A PROCESS AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF PLATELET GLYCOPROTEIN IIb/IIIa INHIBITORS CONTAINING N-ALPHA-METHYLARGININE |
| 01/31/1996 | EP0693941A1 Radiolabeled compounds for thrombus imaging |
| 01/31/1996 | EP0693931A1 Immunogenic cancer proteins and peptides and method of use |
| 01/31/1996 | EP0538352B1 IMMUNOGENIC PEPTIDE SEQUENCE FROM $i(ECHINOCOCCUS GRANULOSUS), DNA SEQUENCE CODING FOR SAID PEPTIDE SEQUENCE, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF |
| 01/31/1996 | EP0502928B1 Methods of detecting bone resorption in vivo |
| 01/31/1996 | EP0305488B1 Mycobacterial recombinants and peptides |
| 01/30/1996 | US5488036 Gonadotrophins in cells for polypeptide hormones |
| 01/30/1996 | US5487974 Contact blood samples and determine proliferation of cytolytic lymphocytes and lysis of cells presenting said complexes |
| 01/26/1996 | CA2154141A1 Endothelin-antagonizing peptide |
| 01/26/1996 | CA2154129A1 Endothelin-antagonizing peptide |
| 01/25/1996 | WO1996001901A1 Streptogramines and method for preparing same by mutasynthesis |
| 01/25/1996 | WO1996001847A1 Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown |
| 01/25/1996 | WO1996001846A1 Proinsulin peptide compounds for detecting and treating type i diabetes |
| 01/25/1996 | WO1996001646A1 Invariant chain compositions useful for treating autoimmune diseases |
| 01/25/1996 | WO1996001645A1 Use of muramyl peptide compounds |
| 01/25/1996 | WO1996001644A1 Inhibitors of leukocyte adhesion |
| 01/25/1996 | CA2194678A1 Use of muramyl peptide compounds |
| 01/25/1996 | CA2194550A1 Invariant chain compositions useful for treating autoimmune diseases |
| 01/25/1996 | CA2194548A1 Proinsulin peptide compounds for detecting and treating type i diabetes |
| 01/25/1996 | CA2193508A1 Inhibitors of leukocyte adhesion |
| 01/24/1996 | EP0693122A1 Glutamylcysteine synthetase light subunit |
| 01/24/1996 | EP0693083A1 Alpha-ketoamide derivatives as inhibitors of thrombosis |
| 01/24/1996 | EP0693081A1 Cyclic compounds and compositions which inhibit bone resorption |
| 01/24/1996 | EP0692982A1 RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS |
| 01/24/1996 | EP0692976A1 Chelating agents of the type xn 1?s 1?o 1? for radioactive isotopes, metal complexes thereof, and their use in diagnosis and therapy |
| 01/24/1996 | EP0692971A1 Analogs of peptide yy and uses thereof |
| 01/24/1996 | EP0692968A1 Urokinase plasminogen activator fragments |
| 01/24/1996 | EP0440619B1 Antibody to a4 amyloid peptide |
| 01/24/1996 | CN1115252A Ionic molecular conjugates of biodergaable polyesters and bioactive polypeptides |
| 01/23/1996 | US5486596 Analogues of 8-D-homoarginine vasopressin |
| 01/23/1996 | US5486466 Enzyme inhibitors |
| 01/23/1996 | US5486465 Teicoplanin recovery process |
| 01/23/1996 | US5486453 Antibodies to human papillomavirus latent proteins, diagnostic systems and methods |